--GlaxoSmithKline PLC shareholders have backed the company over concerns that activist U.S. hedge fund Elliott Management is set to push for a shakeup, The Times reports.

--Several top 20 shareholders in the British pharmaceutical company have contacted Chairman Jonathan Symonds to express support for the board and its current strategy, according to The Times.

--Elliott hasn't yet revealed its intentions to the company but has begun to engage with other leading shareholders, The Times reports.


Full story: https://bit.ly/3hDWgn8


Write to Barcelona editors at barcelonaeditors@dowjones.com


(END) Dow Jones Newswires

May 17, 2021 09:17 ET (13:17 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.